Accessibility settings

This paper is in the following e-collection/theme issue:

Cancer Epidemiology, Cancer Surveillance and Infodemiology (129) Cancer Survivorship (363) Lung Cancer (73) Chemotherapy and Side Effects Management (123) Dementia and Cognitive Decline (746)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/59647, first published .
Relationship Between Cognitive Disorder and First-Line Targeted Therapy for Oncogene Driver–Positive Patients With Non–Small Cell Lung Cancer: Prospective Cohort Study

Relationship Between Cognitive Disorder and First-Line Targeted Therapy for Oncogene Driver–Positive Patients With Non–Small Cell Lung Cancer: Prospective Cohort Study

Relationship Between Cognitive Disorder and First-Line Targeted Therapy for Oncogene Driver–Positive Patients With Non–Small Cell Lung Cancer: Prospective Cohort Study

Authors of this article:

Wenjun Chen1 Author Orcid Image ;   Xueyang Hu2 Author Orcid Image ;   Senbang Yao3 Author Orcid Image ;   Ziran Bi3 Author Orcid Image ;   Maoxi Chen1 Author Orcid Image ;   Huaidong Cheng4, 5 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Voynov M, Pospelova M, Nikolaeva A, Krasnikova V, Makhanova A, Fionik O, Samochernykh K, Alekseeva T, Combs S, Shevtsov M. Multimodal Cancer Therapy and Accelerated Brain Aging: Mechanisms, Biomarkers, and Clinical Consequences. Current Oncology 2026;33(2):121 View